Johnson & Johnson Development Corp Et Al

Affiliated Entities

Achillion Pharmaceuticals, Inc.	Aquinox Pharmaceuticals (usa) Inc	Barrier Therapeutics, Inc.	Celebrity Sports Networks Inc	Critical Therapeutics, Inc.
Cvrx, Inc.	Genocea Biosciences, Inc.	Immunicon Corp	Infospace.com, Inc.	Inspire Medical Systems, Inc.
Johnson & Johnson Consumer Companies, Inc.	Johnson & Johnson, Inc.	Minerva Neurosciences, Inc.	Neuron Systems, Inc.	Nevro Corp
Protagonist Inc	Provention Bio, Inc.	Tengion, Inc.	Universal Biosensors Inc

On PlainSite Chat

No one has posted about Johnson & Johnson Development Corp Et Al yet.

Share something about Johnson & Johnson Development Corp Et Al:

An active PlainSite Pro or Pro Se subscription is required to view the Activity Timeline.

Outside Counsel (0)

This table is empty.

Insider Trading History

SEC Filings

Filter By Form All Records 3 3/A 4 4/A 5 From To

	Date	Entity	Form Number	Description	Value
	5/13/2026		13F-NT	Form 13F notice (no securities to report)
	2/13/2026		13F-NT	Form 13F notice (no securities to report)
	1/8/2026	Carpenter Melanie	4/A	Amendment to statement of changes in beneficial ownership of sec...
	12/1/2025	Cvrx, Inc.	4	Statement of changes in beneficial ownership of securities	$63.6K
	11/25/2025	Cvrx, Inc.	4	Statement of changes in beneficial ownership of securities	$27.1K
	11/14/2025	Cvrx, Inc.	4	Statement of changes in beneficial ownership of securities	$10.0K
	11/13/2025		13F-NT	Form 13F notice (no securities to report)
	11/10/2025	Cvrx, Inc.	4	Statement of changes in beneficial ownership of securities	$536.3K
	8/27/2025		N-PX	Annual report of proxy voting record
	7/22/2025		13F-NT	Form 13F notice (no securities to report)
	5/7/2025		13F-NT	Form 13F notice (no securities to report)
	2/13/2025		13F-NT	Form 13F notice (no securities to report)
	11/13/2024		13F-NT	Form 13F notice (no securities to report)
	8/29/2024		N-PX	Annual report of proxy voting record
	8/9/2024		13F-NT	Form 13F notice (no securities to report)
	5/10/2024		13F-NT	Form 13F notice (no securities to report)
	4/10/2024	Contineum Therapeutics, Inc.	3	Initial statement of beneficial ownership of securities
	3/6/2024	Cvrx, Inc.	4	Statement of changes in beneficial ownership of securities	$195.0K
	2/14/2024		13F-NT	Form 13F notice (no securities to report)
	11/16/2023		SC 13G	Statement of beneficial ownership by passive investors
	11/9/2023		13F-NT	Form 13F notice (no securities to report)
	9/18/2023	MeiraGTx Holdings plc	4	Statement of changes in beneficial ownership of securities
	9/18/2023	Cvrx, Inc.	4	Statement of changes in beneficial ownership of securities
	9/18/2023	MeiraGTx Holdings plc	3	Initial statement of beneficial ownership of securities
	9/18/2023	Cvrx, Inc.	3	Initial statement of beneficial ownership of securities
	8/2/2023		13F-NT	Form 13F notice (no securities to report)
	5/11/2023		13F-NT	Form 13F notice (no securities to report)
	2/9/2023		13F-NT	Form 13F notice (no securities to report)
	11/14/2022	MeiraGTx Holdings plc	3	Initial statement of beneficial ownership of securities
	11/10/2022		13F-NT	Form 13F notice (no securities to report)
	8/10/2022		13F-NT	Form 13F notice (no securities to report)
	5/9/2022		13F-NT	Form 13F notice (no securities to report)
	2/14/2022		13F-NT	Form 13F notice (no securities to report)
	11/12/2021		13F-NT	Form 13F notice (no securities to report)
	8/3/2021		13F-HR	Quarterly report on institutional investment holdings (Form 13F)
	7/2/2021	Cvrx, Inc.	4	Statement of changes in beneficial ownership of securities
	6/29/2021	Cvrx, Inc.	3	Initial statement of beneficial ownership of securities
	5/6/2021		13F-HR	Quarterly report on institutional investment holdings (Form 13F)
	2/9/2021		13F-HR	Quarterly report on institutional investment holdings (Form 13F)
	11/3/2020		13F-HR	Quarterly report on institutional investment holdings (Form 13F)
	8/12/2020		13F-HR	Quarterly report on institutional investment holdings (Form 13F)
	7/2/2020	Fusion Pharmaceuticals Inc.	4	Statement of changes in beneficial ownership of securities	$12.33M
	6/25/2020	Fusion Pharmaceuticals Inc.	3	Initial statement of beneficial ownership of securities
	5/13/2020		13F-HR	Quarterly report on institutional investment holdings (Form 13F)
	2/14/2020		13F-HR	Quarterly report on institutional investment holdings (Form 13F)
	7/20/2018	Celebrity Sports Networks Inc	4	Statement of changes in beneficial ownership of securities
	7/3/2018	Provention Bio, Inc.	3	Initial statement of beneficial ownership of securities
	5/7/2018	Infospace.com, Inc.	4	Statement of changes in beneficial ownership of securities
	5/2/2018	Inspire Medical Systems, Inc.	3	Initial statement of beneficial ownership of securities
	11/22/2017	Achillion Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$50.51M

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.

Affiliated Entities

• Achillion Pharmaceuticals, Inc.
• Aquinox Pharmaceuticals (usa) Inc
• Barrier Therapeutics, Inc.
• Celebrity Sports Networks Inc
• Critical Therapeutics, Inc.
• Cvrx, Inc.
• Genocea Biosciences, Inc.
• Immunicon Corp
• Infospace.com, Inc.
• Inspire Medical Systems, Inc.
• Johnson & Johnson Consumer Companies, Inc.
• Johnson & Johnson, Inc.
• Minerva Neurosciences, Inc.
• Neuron Systems, Inc.
• Nevro Corp
• Protagonist Inc
• Provention Bio, Inc.
• Tengion, Inc.
• Universal Biosensors Inc